Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 97

    1.

    The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: a pilot study.

    Mavropoulos JC, Yancy WS, Hepburn J, Westman EC.

    Nutr Metab (Lond). 2005 Dec 16;2:35.PMID: 16359551 [PubMed]Related articlesFree article

    2.

    Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.

    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.

    Fertil Steril. 2008 Apr;89(4):899-906. Epub 2007 Nov 5.PMID: 17980364 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.

    Wu J, Zhu Y, Jiang Y, Cao Y.

    Gynecol Endocrinol. 2008 Jul;24(7):392-8.PMID: 18608522 [PubMed - indexed for MEDLINE]Related articles

    5.

    The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome.

    Thomson RL, Buckley JD, Noakes M, Clifton PM, Norman RJ, Brinkworth GD.

    J Clin Endocrinol Metab. 2008 Sep;93(9):3373-80. Epub 2008 Jun 26.PMID: 18583464 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Glucose intolerance in Japanese patients with polycystic ovary syndrome.

    Kurioka H, Takahashi K, Miyazaki K.

    Arch Gynecol Obstet. 2007 Mar;275(3):169-73. Epub 2006 Sep 14.PMID: 16972071 [PubMed - indexed for MEDLINE]Related articles

    7.

    Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.

    Panidis D, Rousso D, Koliakos G, Kourtis A, Katsikis I, Farmakiotis D, Votsi E, Diamanti-Kandarakis E.

    Fertil Steril. 2006 Jun;85(6):1778-83. Epub 2006 May 2.PMID: 16650418 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome]

    Li X, Lin JF.

    Zhonghua Yi Xue Za Zhi. 2005 Dec 7;85(46):3266-71. Chinese. PMID: 16409817 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.

    Diamanti-Kandarakis E, Katsikis I, Piperi C, Alexandraki K, Panidis D.

    Clin Endocrinol (Oxf). 2007 Jan;66(1):103-9.PMID: 17201808 [PubMed - indexed for MEDLINE]Related articles

    10.

    Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.

    Guzelmeric K, Alkan N, Pirimoglu M, Unal O, Turan C.

    Gynecol Endocrinol. 2007 Sep;23(9):505-10.PMID: 17852421 [PubMed - indexed for MEDLINE]Related articles

    11.

    C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome.

    Moran LJ, Noakes M, Clifton PM, Wittert GA, Belobrajdic DP, Norman RJ.

    J Clin Endocrinol Metab. 2007 Aug;92(8):2944-51. Epub 2007 May 15.PMID: 17504892 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Infertility and polycystic ovarian syndrome: a study of association between body mass index and intrafamily marriages.

    Haq F, Rizvi J.

    Gynecol Obstet Invest. 2008;65(4):269-74. Epub 2008 Jan 15.PMID: 18196937 [PubMed - indexed for MEDLINE]Related articles

    13.

    Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome.

    Micic D, Sumarac-Dumanovic M, Kendereski A, Cvijovic G, Zoric S, Pejkovic D, Micic J, Milic N, Dieguez C, Casanueva FF.

    J Endocrinol Invest. 2007 Nov;30(10):820-7.PMID: 18075283 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Epidemiological study of clinical characteristics of Chinese Han ethnic women with polycystic ovary syndrome]

    Zhao JL, Chen ZJ, Zhao LX, Geng L, Wang S, Gao SS, Zhang P, Liu S, Zhou FR.

    Zhonghua Fu Chan Ke Za Zhi. 2006 Jun;41(6):375-9. Chinese. PMID: 16831357 [PubMed - indexed for MEDLINE]Related articles

    15.

    Difference in dietary intake between women with polycystic ovary syndrome and healthy controls.

    Douglas CC, Norris LE, Oster RA, Darnell BE, Azziz R, Gower BA.

    Fertil Steril. 2006 Aug;86(2):411-7. Epub 2006 Jun 8.PMID: 16762348 [PubMed - indexed for MEDLINE]Related articles

    16.

    Polymorphism T --> C (-34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study.

    Echiburú B, Pérez-Bravo F, Maliqueo M, Sánchez F, Crisosto N, Sir-Petermann T.

    Metabolism. 2008 Dec;57(12):1765-71.PMID: 19013303 [PubMed - indexed for MEDLINE]Related articles

    17.

    Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance.

    Ketel IJ, Stehouwer CD, Serné EH, Korsen TJ, Hompes PG, Smulders YM, de Jongh RT, Homburg R, Lambalk CB.

    J Clin Endocrinol Metab. 2008 Sep;93(9):3365-72. Epub 2008 Jul 1.PMID: 18593766 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome.

    Moran LJ, Noakes M, Clifton PM, Norman RJ.

    J Clin Endocrinol Metab. 2007 Oct;92(10):3796-802. Epub 2007 Jul 24.PMID: 17652213 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.

    Yilmaz M, Biri A, Karakoç A, Törüner F, Bingöl B, Cakir N, Tiras B, Ayvaz G, Arslan M.

    J Endocrinol Invest. 2005 Dec;28(11):1003-8.PMID: 16483179 [PubMed - indexed for MEDLINE]Related articles

    20.

    A low-carbohydrate, ketogenic diet to treat type 2 diabetes.

    Yancy WS Jr, Foy M, Chalecki AM, Vernon MC, Westman EC.

    Nutr Metab (Lond). 2005 Dec 1;2:34.PMID: 16318637 [PubMed]Related articlesFree article

    Supplemental Content

    Find related data